Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment

Scritto il 05/01/2026
da Kimberly Loh

No abstract

Rheumatol Adv Pract. 2025 Dec 6;10(1):rkaf141. doi: 10.1093/rap/rkaf141. eCollection 2026.

NO ABSTRACT

PMID:41488193 | PMC:PMC12758113 | DOI:10.1093/rap/rkaf141